Protease-activated receptor 2
Protease-activated receptor 2 (PAR2) is a member of the protease-activated receptor family, which are a subset of G protein-coupled receptors (GPCRs). These receptors are unique in that they are activated by the cleavage of part of their extracellular domain by specific proteases.
Structure[edit | edit source]
PAR2 is a transmembrane protein that spans the cell membrane seven times, characteristic of GPCRs. The receptor is activated when a protease cleaves its extracellular N-terminus, revealing a new N-terminus that acts as a tethered ligand, binding intramolecularly to the receptor to initiate signal transduction.
Activation and Signaling[edit | edit source]
PAR2 can be activated by various proteases, including trypsin, tryptase, and certain coagulation factors. Upon activation, PAR2 couples with G proteins, leading to the activation of multiple intracellular signaling pathways, including the phospholipase C pathway, which results in the production of inositol trisphosphate (IP3) and diacylglycerol (DAG), and the activation of protein kinase C (PKC).
Physiological Roles[edit | edit source]
PAR2 is expressed in various tissues, including the gastrointestinal tract, skin, lungs, and immune system. It plays a role in numerous physiological processes such as inflammation, pain perception, wound healing, and immune response.
Inflammation[edit | edit source]
PAR2 is involved in the regulation of inflammatory responses. Activation of PAR2 on immune cells can lead to the release of pro-inflammatory cytokines and chemokines, contributing to the inflammatory process.
Pain Perception[edit | edit source]
PAR2 activation has been linked to the modulation of pain. It can sensitize nociceptors, the sensory neurons responsible for pain detection, thereby enhancing pain perception.
Wound Healing[edit | edit source]
PAR2 plays a role in the wound healing process by promoting the migration and proliferation of keratinocytes and fibroblasts, which are essential for tissue repair.
Clinical Significance[edit | edit source]
Dysregulation of PAR2 signaling has been implicated in various pathological conditions, including chronic inflammatory diseases, cancer, and allergic reactions. As a result, PAR2 is considered a potential therapeutic target for the treatment of these conditions.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD